tradingkey.logo

Virax Biolabs Group Ltd

VRAX

0.850USD

+0.005+0.57%
Close 08/04, 16:00ETQuotes delayed by 15 min
3.69MMarket Cap
--P/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025H1
FY2024H2
FY2024H1
FY2023H2
FY2023H1
Total revenue
-93.53%4.95K
2753.23%79.92K
1228.13%76.50K
--2.80K
--5.76K
Revenue
-93.53%4.95K
2753.23%79.92K
1228.13%76.50K
--2.80K
--5.76K
Cost of revenue
-82.68%11.43K
830.14%39.85K
1069.48%65.98K
--4.28K
--5.64K
Operating expenses
3.63%2.88M
-18.98%3.48M
92.40%2.78M
--4.29M
--1.45M
R&D expenses
77.48%726.41K
283.60%1.15M
323.60%409.30K
--300.49K
--96.62K
Depreciation, depletion, and amortization
792.78%158.19K
--85.38K
--17.72K
----
----
Operating profit
-6.38%-2.88M
20.79%-3.40M
-87.86%-2.71M
---4.29M
---1.44M
Net non-operating interest income (expenses)
Non-operating interest income
----
--3.15K
----
----
----
Non-operating interest expense
153.03%25.59K
239.85%19.91K
5.27%10.11K
--5.86K
--9.61K
Special income (expenses)
-100.00%0.00
---402.82K
--12.46K
----
----
Other non-operating income (expenses)
105.35%11.26K
-101.85%-5.44K
-5739.31%-210.33K
--294.07K
---3.60K
Income before tax
0.72%-2.89M
4.47%-3.82M
-100.46%-2.91M
---4.00M
---1.45M
Income tax
---136.66K
----
----
----
----
Income after tax
5.41%-2.76M
4.47%-3.82M
-100.46%-2.91M
---4.00M
---1.45M
Net income from continuous operations
5.41%-2.76M
4.47%-3.82M
-100.46%-2.91M
---4.00M
---1.45M
Net Income attributable to non-controlling interests
96.99%-137.00
-110.41%-1.03K
55.26%-4.55K
--9.91K
---10.18K
Net income attributable to controlling interests
5.27%-2.76M
4.73%-3.82M
-101.55%-2.91M
---4.01M
---1.44M
Net income attributable to common shareholders
5.27%-2.76M
4.73%-3.82M
-101.55%-2.91M
---4.01M
---1.44M
Basic earnings per share
45.81%-0.89
26.08%-1.71
55.75%-1.64
---2.31
---3.70
Diluted earnings per share
45.81%-0.89
26.08%-1.71
55.75%-1.64
---2.31
---3.70
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
KeyAI